Table 2.
Rates of evolution in plasma HIV-1 RNA and PBMC HIV-1 DNA sequences obtained before the start and after the start of suppressive antiretroviral therapy, respectively.
Patient | RNA rate |
DNA rate |
||
---|---|---|---|---|
[Year−1] | p-value | [Year−1] | p-value | |
p1 | 4.4 × 10−3 |
<10−6 |
−6 × 10−4 |
0.22 |
p2 | 3.7 × 10−3 |
<10−2 |
−8 × 10−4 |
– |
p3 | 4.1 × 10−3 |
<10−6 |
−2 × 10−4 |
0.39 |
p5 | 4.8 × 10−3 |
<10−3 |
4 × 10−4 |
0.45 |
p6 | 1.4 × 10−3 |
<10−3 |
−9 × 10−4 |
0.22 |
p7 | 1.3 × 10−3 |
<10−2 |
−7 × 10−4 |
0.14 |
p8 | 2.9 × 10−3 |
<10−5 |
8 × 10−5 |
0.22 |
p9 | 2.6 × 10−3 |
<10−4 |
1 × 10−4 |
0.12 |
p10 | 3.6 × 10−3 |
<10−5 |
−1 × 10−4 |
0.20 |
p11 | 1.2 × 10−3 |
<10−2 |
2 × 10−4 |
0.16 |